Cargando…
SAT-505 A Rare Case of Teriparatide Induced Persistent Hypercalcemia
INTRODUCTION Teriparatide is a recombinant endogenous parathyroid hormone. It is an anabolic medication which is FDA approved for treating Osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis and Glucocorticoid-induced osteoporosis. Transient hypercalcemia with Teripara...
Autores principales: | Sistla, Divya, Mehrotra, Neha, Mon, Sann Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552103/ http://dx.doi.org/10.1210/js.2019-SAT-505 |
Ejemplares similares
-
MON-358 Hypercalcemia During Teriparatide Therapy
por: Milosavljevic, Jovan, et al.
Publicado: (2020) -
SAT-345 Etanercept Induced Hypercalcemia
por: Chaker, Bayan, et al.
Publicado: (2020) -
SAT-501 A Rare and Potentially Fatal Etiology of Hypercalcemia in an Infant
por: Sonawalla, Ambreen, et al.
Publicado: (2019) -
SAT-502 Bisphosphonates for Treatment of Calcitriol-Induced Hypercalcemia
por: Mateo, Roselyn Cristelle, et al.
Publicado: (2019) -
SAT244 Hypercalcemia Induced By Inconspicuous Histoplasmosis Infection
por: Alkhathlan, Mujahed, et al.
Publicado: (2023)